The Determination of Antithrombin III

Summary

At III levels were measured with six methods in 36 people: 10 healthy controls, 10 women taking a progestagen Lynestrenol and 16 women taking a combined oestrogen-progestagen contraceptive pill.

The reproducibility and the sensitivity of these methods as well as the correlation between methods were studied.

The Hensen and Loeliger technique had a poor reproducibility and the results obtained with the Howie technique were not in good correlation with those obtained with the other methods, especially in the group taking oral contraceptives. The two amidolytic methods using chromogenic substrates were found to be very accurate for antithrombin III activity determination. The rocket Immunoelectrophoresis was more accurate and more practical than the radial immunodiffusion.

With all methods - except the one of Howie–the 10 women taking progestagen Lynestrenol and the 16 taking combined oestrogen-progestagen had a low AT III and differed significantly from the 10 normals tested. No difference was observed between women taking progestagen only or an oestrogen-progestagen combination.

• References

• 1 Adlercreutz H, Tenhunen R. 1970; Some aspects of the interaction between natural and synthetic Female Sex Hormones and the liver. American Journal of Medicine 49: 630
• 2 Astedt B, Isacson S, Nilsson IM, Pandolfi M. 1973; Thrombosis and oral Contraceptives: possible Predisposition. British Medical Journal 4: 631
• 3 Blömback M, Blömback B, Olsson P, Svendsen L. 1974; The Assay of Antithrombin using a synthetic chromogenic substrate for Thrombin. Thrombosis Research 5: 621
• 4 Bounameaux H. 1976 unpublished data.
• 5 Conard J, Samama M, Salomon Y. 1972; Antithrombin III and the Oestrogen Content of combined Oestro-Progestagen Contraceptives. Lancet II: 1149
• 6 Duckert F. 1972; Influence of the Contraception on the Haemostasis. VASA 1: 219
• 7 Egeberg O. 1965; Inherited Antithrombin Deficiency causing Thrombophilia. Thrombosis et Diathesis Haemorrhagica 13: 516
• 8 Gjønaess H, Fagerhol MK. 1971 Und International Congress on Thrombosis and Haemostasis, Oslo, Norway, Abstracts. page 20
• 9 Hensen A, Loeliger EA. 1963 Antithrombin III: Its Metabolism and its Function in Blood Coagulation. Thrombosis et Diathesis Haemorrhagica. 9 Suppl I
• 10 Howie PW, Mallison AC, Prentice CRM. 1970; Effect of combined Oestrogen-Progestagen Contraceptive, Oestrogen and Progestagen on Antiplasmin and Antithrombin Activity. Lancet II: 1329
• 11 Howie PW, Prentice CRM, Mcnicol GP. 1973; A Method of Antithrombin Estimation using Plasma defibrinated with Ancrod. British Journal of Haematology 25: 101
• 12 Inman WHW, Vessey MP, Westerholm B, Engelund A. 1970; Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A report to the Committee on Safety of Drugs. British Medical Journal 2: 203
• 13 Jordan WM. 1961; Pulmonary Embolism. Letter to the Editor. Lancet II: 1146
• 14 Laurell CB. 1966; Quantitative Estimation of Proteins by Electrophoresis in Agarose Gel containing Antibodies. Annals of Biochemistry 15: 45
• 15 Mancini G, Carbonara AO, Heremans JF. 1965; Immunochemical Quantitation of Antigens by simple radial Immunodiffusion. International Journal of Immunochemistry 2: 235
• 16 Mann JI, Inman WHW. 1975; Oral Contraceptives and Death from myocardial Infarction. British Medical Journal 2: 245
• 17 Müller PH. 1965; Rezidivierende Lungenembolien mit sekundärer Thrombose der Pulmonalarterien bei Einnahme eines oralen Ovulationshemmers. Schweizerische Medizinische Wochenschrift 95: 1367
• 18 Nagasawa H, Hotta Y, Takara N, Fujimaki M, Fukutake K. 1975; Inhibitory Effects of Estrogens on Antithrombin III. Thrombosis et Diathesis Haemorrhagica 34: 345
• 19 Ødegaard OR, Lie M, Abildgaard U. 1974; Heparin Cofactor Activity measured with an amidolytic Method. Thrombosis Research 6: 287
• 20 Ødegaard OR. 1975; Evaluation of an amidolytic Heparin Cofactor Assay Method. Thrombosis Research 7: 351
• 21 Poller L, Thomson JM, Thomas W. 1972; Effect of Progestagen Oral Contraception with Norethisterone on Blood Clotting and Platelets. British Medical Journal 4: 391
• 22 Reutter F, Siebenmann R, Wegmann T. 1965; TödlicheLungenembolie bei Verabreichung eines Ovulationshemmers. Schweizerische Medizinische Wochenschrift 95: 303
• 23 Vessey MP, Doll R. 1968; Investigation of Relation between Use of oral Contraceptives and thromboembolic Disease. British Medical Journal 2: 199
• 24 Vessey MP, Weatherall JAC. 1969; Venous thromboembolic Disease and the Use of Contraceptives. A review of Mortality Statistics in England and Wales. Lancet II: 94